by SD-AbarceoPharma | Oct 1, 2026 | Diabetes, Events, Investors
Abarceo is happy to attend at the Biostock Life Science Summit in Lund, November 4–5. BioStock Summit returns for its 9th edition, bringing together companies, investors and industry professionals from across the Nordic life science sector. Over two days, emerging and...
by SD-AbarceoPharma | Sep 29, 2026 | Diabetes, Events, News & Press releases
EASD Annual Meeting 2026 We are proud that our Science Director Ruchi Jain and our founder Claes Wollheim will be attending and presenting our recent findings in Diabetes Type 1 at the EASD 2026. The 62nd EASD Annual Meeting will be held in Milan, Italy, from 28...
by SD-AbarceoPharma | Sep 28, 2026 | Diabetes, Events, Investors
Abarceo Pharma | Investing in Life Science 2026 CEO Adam Bruce presents Abarceo Pharma at Investing in Life Science 2026.
by SD-AbarceoPharma | Sep 11, 2026 | Diabetes, Events, Investors, News & Press releases
On September 22, BioStock’s Investing in Life Science 2026 event took place in Stockholm. This exclusive investor event brings together leading life science companies from across the region with investors seeking new opportunities and strategic partnerships at various...
by SD-AbarceoPharma | May 15, 2026 | Events, Investors
Abarceo’s CEO Adam Bruce participated at the Almi Invest Rooftop Mingle on May 7th and gave an inspiring presentation. “I’m grateful for the opportunity to take part in this important event,” says Adam Bruce. ...
by SD-AbarceoPharma | Apr 30, 2026 | Diabetes, Events, Investors, News & Press releases
Abarceo is participating in the upcoming Redeye Theme Event Diabetes 2026! We’re proud to present Abarceo at the main diabetes business and finance event in Sweden, The Redeye Theme Event Diabetes 2026 on May 6! This focused seminar is intended to give investors...
Recent Comments